Maurizio Scaltriti

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

Pedram Razavi, Matthew T. Chang, Guotai Xu et al. · Cancer Cell · 2018 · 1K citations · Full text

Medicine, Genetics, Oncology +14

AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity

Sarat Chandarlapaty, Ayana Sawai, Maurizio Scaltriti et al. · Cancer Cell · 2011 · 958 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14

Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer

Maurizio Scaltriti, Federico Rojo, Alberto Ocaña et al. · JNCI Journal of the National Cancer Institute · 2007 · 881 citations · Full text

Medicine, Cancer Biology, Oncology +17

NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations

Violeta Serra, Ben Markman, Maurizio Scaltriti et al. · Cancer Research · 2008 · 796 citations · Full text

Medicine, Oncology, Pharmacology +16

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

David M. Hyman, Sarina A. Piha‐Paul, Helen Won et al. · Nature · 2018 · 783 citations

Medicine, Cancer Biology, Oncology +14